141 related articles for article (PubMed ID: 30016858)
1. Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kang GH
J Pathol Transl Med; 2018 Sep; 52(5):298-306. PubMed ID: 30016858
[TBL] [Abstract][Full Text] [Related]
2. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
[TBL] [Abstract][Full Text] [Related]
3. EphB2 is a prognostic factor in colorectal cancer.
Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
[TBL] [Abstract][Full Text] [Related]
4. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
6. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
7. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance.
Zhang Z; Ren H; Yang L; Zhang X; Liang W; Wu H; Huang L; Kang J; Xu J; Zhai E; Cai S; He Y
Hum Pathol; 2018 Sep; 79():135-143. PubMed ID: 29879402
[TBL] [Abstract][Full Text] [Related]
10. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
11. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of stromal GREM1 expression in colorectal cancer.
Jang BG; Kim HS; Chang WY; Bae JM; Oh HJ; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Hum Pathol; 2017 Apr; 62():56-65. PubMed ID: 28041973
[TBL] [Abstract][Full Text] [Related]
13. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of junctional adhesion molecule-A and EphB2 predicts poor survival in lung adenocarcinoma patients.
Zhao C; Wang A; Lu F; Chen H; Fu P; Zhao X; Chen H
Tumour Biol; 2017 Feb; 39(2):1010428317691000. PubMed ID: 28231727
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRK6 associates with the progression and prognosis of colorectal carcinoma.
Tao R; Li Q; Gao X; Ma L
Oncol Lett; 2018 Apr; 15(4):5879-5886. PubMed ID: 29552218
[TBL] [Abstract][Full Text] [Related]
16. EPHB2 expression is associated with intestinal phenotype of gastric cancer and indicates better prognosis by suppressing gastric cancer migration.
Kim H; Myung JK; Paik SS; Kim H; Park H; Kim YJ; Lee SB; Kim HU; Song HJ; Jeong IH; Hong S; Park CM; Lee C; Kim Y; Jang B
Am J Cancer Res; 2022; 12(3):1295-1308. PubMed ID: 35411225
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C
J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719
[TBL] [Abstract][Full Text] [Related]
19. A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis.
Rafael S; Vidaurreta M; Veganzones S; De La Orden V; Mediero B; Gutierrez ML; Maestro ML
Anticancer Res; 2013 Nov; 33(11):5159-63. PubMed ID: 24222164
[TBL] [Abstract][Full Text] [Related]
20. EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa AM; Magić Ž; Larsson M; Fornander T; Pérez-Tenorio G
Oncotarget; 2016 Apr; 7(16):21362-80. PubMed ID: 26870995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]